CoChat

Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein

Open access
Du, Jian, Stankiewicz, Monika J., Liu, Yang, Xi, Qing, Schmitz, Jonathan E., Lekstrom-Himes, Julie A., Ackerman, Steven J. · 2002 · Journal of Biological Chemistry

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index; 15 of the 82 sources its claims cite were checked for support.

Abstract

GATA-1 and the ets factor PU.1 have been reported to functionally antagonize one another in the regulation of erythroid versus myeloid gene transcription and development. The CCAAT enhancer binding protein epsilon (C/EBPepsilon) is expressed as multiple isoforms and has been shown to be essential to myeloid (granulocyte) terminal differentiation. We have defined a novel synergistic, as opposed to antagonistic, combinatorial interaction between GATA-1 and PU.1, and a unique repressor role for certain C/EBPepsilon isoforms in the transcriptional regulation of a model eosinophil granulocyte gene, the major basic protein (MBP). The eosinophil-specific P2 promoter of the MBP gene contains GATA-1, C/EBP, and PU.1 consensus sites that bind these factors in nuclear extracts of the eosinophil myelocyte cell line, AML14.3D10. The promoter is transactivated by GATA-1 alone but is synergistically transactivated by low levels of PU.1 in the context of optimal levels of GATA-1. The C/EBPepsilon(27) isoform strongly represses GATA-1 activity and completely blocks GATA-1/PU.1 synergy. In vitro mutational analyses of the MBP-P2 promoter showed that both the GATA-1/PU.1 synergy, and repressor activity of C/EBPepsilon(27) are mediated via protein-protein interactions through the C/EBP and/or GATA-binding sites but not the PU.1 sites. Co-immunoprecipitations using lysates of AML14.3D10 eosinophils show that both C/EBPepsilon(32/30) and epsilon(27) physically interact in vivo with PU.1 and GATA-1, demonstrating functional interactions among these factors in eosinophil progenitors. Our findings identify novel combinatorial protein-protein interactions for GATA-1, PU.1, and C/EBPepsilon isoforms in eosinophil gene transcription that include GATA-1/PU.1 synergy and repressor activity for C/EBPepsilon(27).

Overview

CoChat Summary

TL;DR

This paper defines a novel synergistic, rather than antagonistic, interaction between GATA-1 and PU.1 at the eosinophil MBP-P2 promoter, and identifies C/EBPε27 as a repressor of GATA-1 and GATA-1/PU.1 transactivation. It also shows that C/EBPε32/30 and C/EBPε27 physically interact with PU.1 and GATA-1 in eosinophil cell lysates.

Key findings

  • The MBP-P2 promoter contains two GATA, two C/EBP, and two PU.1 consensus sites; GATA-1 bound the dual GATA sites, PU.1 bound both PU.1 sites, and C/EBPβ/C/EBPε bound the first C/EBP site in AML14.3D10 nuclear extracts.
  • GATA-1 alone induced MBP-P2 activity ~20-fold, while GATA-1 plus low PU.1 induced ~60-fold; in another assay GATA-1/PU.1 synergy was ~75-fold. High PU.1 abrogated synergy, and mutation of the PU.1 sites had essentially no effect, indicating protein-protein interaction rather than direct PU.1 DNA binding.
  • C/EBPε27 strongly repressed GATA-1 transactivation and completely blocked GATA-1/PU.1 synergy, while C/EBPε32 and C/EBPε14 did not; C/EBPε27 also blocked PU.1-mediated M-CSFR transactivation.
  • Co-immunoprecipitation showed C/EBPε32/30 and C/EBPε27 physically interact with PU.1 and GATA-1 in AML14.3D10 lysates; C/EBPε14 was not co-immunoprecipitated. In C/EBPε null mice, MBP mRNA was only partially decreased (~50%), whereas C/EBPα null mice showed no detectable MBP expression.

Methods

  • Binding was assessed by EMSA and antibody supershift assays using nuclear extracts from AML14.3D10 eosinophil myelocytes, AML14 parental myeloblasts, and mature peripheral blood eosinophils (>99% purity).
  • Functional analyses used MBP-P2 luciferase reporter constructs with mutated GATA, C/EBP, or PU.1 sites in CV-1 cells and by transient transfection/electroporation in AML14 and AML14.3D10 cells; K562 cells were used for endogenous GATA-1 context.
  • Protein interactions were tested by Western blotting and co-immunoprecipitation from AML14.3D10 whole-cell lysates; MBP mRNA in C/EBPα- and C/EBPε-deficient mice was measured by semi-quantitative RT-PCR with GAPDH normalization.

Limitations

  • The paper states that the GATA-1 null mutation in the mouse had not been evaluated for eosinophil development, though a note added in proof cites a later report of selective eosinophil loss after deletion of a high-affinity GATA-binding site.
  • The paper states that PU.1 could not be co-immunoprecipitated with C/EBPε or GATA-1, possibly because endogenous PU.1 is low in AML14.3D10 cells or because antibodies blocked interactions.
  • The paper notes that murine C/EBPε encodes only a single full-length 34-kDa isoform, with no murine equivalents of the human 27- and 14-kDa isoforms, suggesting human versus murine differences; evident from the text, the mechanistic model relies heavily on heterologous CV-1 overexpression and cell lines, and in vivo occupancy studies were still in progress.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1074/jbc.m204777200

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

10 Valid · 0 Not valid · 30 Not checked · 100 Own results and interpretations

74 more claims · 4 with their cited sources checked

Create a free account to see all 140 claims and to verify the 67 references still open.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 51
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Research works printed but not linked: 7

  1. Zhang, 1996, Curr. Top. Microbiol. Immunol., 211, 137
  2. Perez, 1994, Mol. Cell. Biol., 14, 5023
  3. Simon, 1996, Curr. Top. Microbiol. Immunol., 211, 113
  4. Paul, 1997, Am. J. Hematol., 56, 79, 10.1002/(sici)1096-8652(199710)56:2 · doi:10.1002/(sici)1096-8652(199710)56:2
  5. Sun, 1996, Curr. Top. Microbiol. Immunol., 211, 173
  6. Evans, 1991, Mol. Cell. Biol., 11, 843
  7. Yamanaka, 1998, Int. J. Mol. Med., 1, 213

Cited by

See all 124

Metadata

Authors
Du, J., Stankiewicz, M. J., Liu, Y., Xi, Q., Schmitz, J. E., Lekstrom-Himes, J. A., & Ackerman, S. J.
Affiliations
  • University of Illinois Chicago (US)
  • National Institutes of Health (US)
Corresponding author
Ackerman, Steven J.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-11
Volume
277
Issue
45
Pages
43481-43494
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1986849847
Cited by
120
References
107
Citations by year
2026: 5 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 7
FWCI
1.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • University of Illinois at Urbana-Champaign
  • U.S. Public Health Service
  • University of Illinois at Chicago
  • National Institute of Allergy and Infectious Diseases (R01AI033043, AI 33043)
  • National Center for Research Resources (M01RR013987)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
GATA-1, PU.1, major basic protein, eosinophils, transcriptional regulation, protein-protein interaction, transcriptional synergy, transcriptional repression, P2 promoter, eosinophil progenitors
MeSH terms
Proto-Oncogene Protein Spi-1, Base Sequence, Blood Donors, Blood Proteins, Cell Nucleus, DNA-Binding Proteins, Eosinophils, Gene Expression Regulation, Humans, Promoter Regions, Genetic, Proto-Oncogene Proteins, Ribonucleases, Transcription Factors, Trans-Activators, Mutagenesis, Leucine Zippers, Consensus Sequence, Sequence Deletion, Protein Isoforms, 5' Untranslated Regions, CCAAT-Enhancer-Binding Proteins, Eosinophil Granule Proteins, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.